+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Tissue Banking Market 2019-2025

  • ID: 4871650
  • Report
  • October 2019
  • Region: Global
  • Orion Market Research Private Limited

FEATURED COMPANIES

  • AMS Biotechnology Ltd.
  • AstaZeneca PLC
  • Beckman Coulter Inc.
  • BioCision LLC.
  • Eppendrof AG
  • GlaxoSmithKline PLC
Global Tissue Banking Market Size, Share & Trends Analysis Report, By Products (Equipment and Consumables & Media,) By Applications (Medical Research, Therapeutics, and Others), and Forecast 2019-2025.

Tissue banking is used to collect human tissues for medical and research applications. Tissues bank stores tissues under cryogenic conditions and are further used in drug discovery and development, clinical trials, medical research, and others. Human Tissues are widely used in the treatment of damaged heart muscles, spinal cord injuries. Advancements in the treatment of cell and tissue disorders have created many prospects for tissue banking. Therefore, there is huge scope for the growth of the market. The global tissue banking market is anticipated to grow at a significant rate during the period 2018-2025.

Increasing demand for regenerative medicines and advancements in tissue preservation and in-house sample testing are estimated to augment the growth of the market. Moreover, an increasing number of biobanks across the globe, advancements in the medical drug discovery and biopharmaceuticals industry and advancements in the treatment of tissue disorders and cells are also estimated to fuel the growth of the market during the forecast period. However, there are certain factors such as storage and stability issues associated with the tissues and high cost of equipment that are considered to be the major constraints in the growth of the market. Besides these restraints, tissue banking market is yet to explore its full potential in the market. Adoption of advanced cosmetics surgeries and emergence of automated tissue banking is estimated to develop numerous expansion opportunities for the growth of the market.

The global tissue banking market is segmented on the basis of the product and applications. On the basis of the product, the market is segmented into equipment and consumables & media. Further, on the basis of the application, the market is segmented into medical research, therapeutics, and others. Therapeutics application of tissue banking is expected to contribute significantly to the market owing to the extensive use of tissues in transplantation and the development of therapies.

On the basis of the geography, the study of the global tissue banking market report covers the analysis of four major regions; North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), and Rest of the World (RoW). North America is expected to hold a significant share in the market owing to the presence of major players in the market. Further, the report covers the analysis of various players operating in the market. Some of the key players operating in the market include Thermo Fisher Scientific Inc., Merck KGaA, Beckman Coulter Inc., Stryker Corp., Zimmer Biomet Holdings Inc., AstraZeneca PLC, Regeneron Pharmaceuticals, Inc., Genzyme Corp., Pfizer Inc., and many others

Research Methodology

The market study of the global tissue banking market is incorporated by extensive primary and secondary research. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The research team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include
  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report is intended for tissue banks, biobanks, biotechnology and pharmaceutical companies, research institutes and academic institutes, government agencies and regulatory bodies, investing companies and venture capitalists, and other market participants for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, different products, and services offered by the company, future market opportunities. The report will serve as a source for a 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions.

Market Segmentation:
1. Global Tissue Banking Market Research and Analysis by Product
2. Global Tissue Banking Market Research and Analysis by Application

The Report Covers
  • Comprehensive research methodology of the global tissue banking market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global tissue banking market.
  • Insights about market determinants which are stimulating the global tissue banking market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AMS Biotechnology Ltd.
  • AstaZeneca PLC
  • Beckman Coulter Inc.
  • BioCision LLC.
  • Eppendrof AG
  • GlaxoSmithKline PLC

1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Thermo Fisher Scientific Inc.
3.3.1.1. Overview
3.3.1.2. Financial Analysis
3.3.1.3. SWOT Analysis
3.3.1.4. Recent Developments
3.3.2. Merck KGaA
3.3.2.1. Overview
3.3.2.2. Financial Analysis
3.3.2.3. SWOT Analysis
3.3.2.4. Recent Developments
3.3.3. Beckman Coulter, Inc.
3.3.3.1. Overview
3.3.3.2. Financial Analysis
3.3.3.3. SWOT Analysis
3.3.3.4. Recent Developments
3.3.4. Stryker Corp.
3.3.4.1. Overview
3.3.4.2. Financial Analysis
3.3.4.3. SWOT Analysis
3.3.4.4. Recent Developments
3.3.5. Zimmer Biomet Holdings, Inc.
3.3.5.1. Overview
3.3.5.2. Financial Analysis
3.3.5.3. SWOT Analysis
3.3.5.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. Global Tissue Banking Market by Products
5.1.1. Equipment
5.1.2. Media & Consumables
5.2. Global Tissue Banking Market by Applications
5.2.1. Medical Research & Drug Development
5.2.2. Therapeutics
5.2.3. Others
6. Regional Analysis
6.1. North America
6.1.1. US
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World
7. Company Profiles
7.1. AMS Biotechnology Ltd.
7.2. AstaZeneca PLC
7.3. Beckman Coulter Inc.
7.4. BioCision LLC.
7.5. BioStorage Technologies, Inc.
7.6. Custom Biogenic Systems, Inc.
7.7. Eppendrof AG
7.8. Genzyme Corp. (A Sanofi Company)
7.9. GlaxoSmithKline PLC
7.10. Merck KGaA
7.11. Organ Recovery Systems, Inc.
7.12. Pfizer Inc.
7.13. Regeneron Pharmaceuticals, Inc.
7.14. Stryker Corp.
7.15. Taylor Wharton
7.16. Tecan Group
7.17. Teva Pharmaceuticals Industries Ltd.
7.18. Thermo Fisher Scientific Inc.
7.19. Zimmer Biomet Holdings, Inc.
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • AMS Biotechnology Ltd.
  • AstaZeneca PLC
  • Beckman Coulter Inc.
  • BioCision LLC.
  • BioStorage Technologies, Inc.
  • Custom Biogenic Systems, Inc.
  • Eppendrof AG
  • Genzyme Corp. (A Sanofi Company)
  • GlaxoSmithKline PLC
  • Merck KGaA
  • Organ Recovery Systems, Inc.
  • Pfizer Inc.
  • Regeneron Pharmaceuticals, Inc.
  • Stryker Corp.
  • Taylor Wharton
  • Tecan Group
  • Teva Pharmaceuticals Industries Ltd.
  • Thermo Fisher Scientific Inc.
  • Zimmer Biomet Holdings, Inc.
Note: Product cover images may vary from those shown